In keeping with government guidelines we re-opened our buildings for lab-based research on 11th June, but with greatly reduced staff numbers. Stringent new measures are in place to ensure that we can operate safely. We continue to work from home wherever this is possible so please contact us by email.
The Wellcome-MRC Institute of Metabolic Science-Metabolic Research Laboratories (IMS-MRL) and its embedded MRC Metabolic Diseases Unit investigate the mechanisms through which metabolic health is maintained and how this is disturbed in disease.
We seek to use that knowledge to aid better treatment and prevention of obesity, Type 2 diabetes and related endocrine and metabolic diseases.
IMS-MRL groups encompass skills in genetics, cell biology, cell signalling, neuroendocrinology, bioenergetics, human and animal physiology, experimental medicine and clinical trials.
The IMS-MRL is the base for the MRC Metabolic Diseases Unit which supports four programmes of research that aim to improve understanding of the mechanisms responsible for obesity and related metabolic diseases.
Together with a Welcome Strategic Award, it also supports core scientific facilities that underpin basic and experimental science at the IMS-MRL.
Latest News
A new review, published by Public Health England in advance of the government’s ‘Better Health’ campaign launched today, considers some…
Why some women don’t need pain relief during childbirth
In a study published this week in the journal Cell Reports, researchers from the University of Cambridge and Addenbrooke’s Hospital,…
Two new videos featuring IMS-MRL researchers
Downloadable artificial pancreas app We reported the launch of the world’s first licensed, downloadable artificial pancreas app for people with…
Research from the Gribble-Reimann group and published this week in Cell Reports has demonstrated the ability to label and maintain…
When two pandemics meet: Why is obesity associated with increased COVID-19 mortality?
A perspective article by Steve O’Rahilly and Sam Lockhart, published this week in MED (a new Cell Press journal) presents…
